NCT00553306View on ClinicalTrials.gov

Laboratory-Treated T Cells and Aldesleukin After Cyclophosphamide in Treating Patients With Stage IV Melanoma

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

August 31, 2010

Study Completion Date

March 31, 2012

Conditions

Recurrent MelanomaStage IV Melanoma

Interventions

BIOLOGICAL

therapeutic autologous lymphocytes

Given IV

BIOLOGICAL

aldesleukin

Given subcutaneously

DRUG

cyclophosphamide

Given IV

PROCEDURE

biopsy

Optional correlative studies

OTHER

immunohistochemistry staining method

Optional correlative studies

OTHER

flow cytometry

Correlative studies

GENETIC

polymerase chain reaction

Correlative studies

Trial Locations (1)

98109

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle

All Listed Sponsors

lead

Fred Hutchinson Cancer Center

OTHER

NCT00553306 - Laboratory-Treated T Cells and Aldesleukin After Cyclophosphamide in Treating Patients With Stage IV Melanoma | Biotech Hunter | Biotech Hunter